AI to develop new therapies

Israel’s Can-Fite (see here previously) is developing small molecule medicines that address oncology and inflammatory diseases. It has partnered with Collaborations Pharma to use AI and Machine Learning techniques that significantly reduce development time and costs.

https://ir.canfite.com/news-events/press-releases/detail/1032/can-fite-to-harness-artificial-intelligence-to-develop

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *